This Solicitation opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DEXTROSE INJECTION,
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicits DEXTROSE 5% INJECTION, USP, 100 ML, packaged in units of 80 (1 PG = 80 EA), under NSN 6505-01-384-1362, with BAXTER HEALTHCARE as the referenced manufacturer and NDC 00338-0551-18. This is a regulated pharmaceutical product subject to FDA oversight, and the acquisition is governed by strict technical and quality standards incorporated from the DLA Master List of Technical and Quality Requirements, including RP001 for packaging, RA001 for technical specifications, RQ011 requiring removal of government identification from non-accepted supplies, and RS016 mandating a non-extendable 24-month shelf life for this TYPE I (CODE M) item. Packaging must conform to commercial standards, with each unit sealed to prevent damage and shipped in externally suitable containers meeting Medical Marking Standard No. 1, which replaces MIL-STD-129; preservation and labeling must also comply with MIL-STD-2073-1E and Special Packaging Instructions MPWNN00001 dated 03/30/1988. Delivery is required within five days after order placement, FOB destination, to locations including Fort Carson, CO, and Fort Bragg, NC, with no variance permitted in quantity. Items must be shipped by the fastest traceable means, prohibiting parcel post. All vendors must be registered in SAM, provide CAGE codes, and submit required representations regarding small business status, socioeconomic programs, and covered telecommunications. The contract prohibits the use of additive manufacturing for this item unless explicitly authorized after an Engineering Support Activity review. Compliance with the Berry Amendment and Buy American Act is mandatory, and contractors must adhere to NIST SP 800-171 cybersecurity requirements, FAR 52.223-3 for hazardous material identification, and DFARS 252.204-7016 regarding covered defense telecommunications. Invoicing and payment must be processed exclusively through WAWF, requiring electronic submission of both invoices and receiving reports for fixed-price items. Offers must align with the latest FAR clauses, including deviations for System for Award Management maintenance, contract type, simplified acquisition terms, and small business representation all updated under Deviation 2026-00038, and must be
General Info
Agency
NAICS
Place of Performance
BLDG 7465 BAD TOELZ RD, FORT CARSON, CO, 80913-4093, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
DEXTROSE 5% INJECTION, USP, 100 ML, 80S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
BAXTER HEALTHCARE NDC 00338-0551-18
U/I PACKAGE OF 80
95037 MABG JARVIS
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 80 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a
SPE2DP-26-T-4124
SECTION B
shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORP IV 04687 P/N 2B0041 BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC00338-0551-18
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017480614 0001 PG 1.000
NSN/MATERIAL:6505013841362
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-384-1362 Quantity: 1 PG Purchase Request: 7017480614QTY: 1 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS